跳至主要内容
临床试验/EUCTR2013-000782-36-BE
EUCTR2013-000782-36-BE进行中(未招募)1 期

Effect of TachoSil® on incidence of symptomatic and radiographic lymphoceles after extended pelvic lymph node dissection in prostate and bladder cancer.

Ghent University Hospital0 个研究点目标入组 200 人开始时间: 2013年6月14日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • -Age > 18 years old
  • -Diagnosis of prostate cancer or bladder cancer on pathology
  • -Undergoing transperitoneal pelvic lymph node dissection.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 150
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 50

排除标准

  • -Previous pelvic surgery or irradiation.
  • -Any type of clotting disorder.

研究者

相似试验

进行中(未招募)
1 期
Efficacy and safety of TachoSil in patients undergoing cystectomy. A pilot study. - TachoSil in urological surgeryThe trial will evaluate the efficacy and safety of TachoSil in patients undergoing cystectomy for bladder cancer and non-malignant bladder disease. TachoSil will be applied to the anastomoses between the ureters and the new bladder made of an isolated intestinal loop. The purpose of applying TachoSil to the anastomoses is to evaluate whether this treatment will reduce the degree of stenosis in the anastomoses and thus reduce the degree of impairment on the renal function.MedDRA version: 9.1Level: LLTClassification code 10005003Term: Bladder cancer
EUCTR2007-003622-18-DKState University Hospital60
招募中
3 期
A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During SurgeryHemorrhage
NCT06664775Corza Medical GmbH116
进行中(未招募)
1 期
se of TachoSil® for the prevention of postoperative complications afterremoval of lymphnodes in groin in vulva cancer patientsVulva cancerMedDRA version: 19.1Level: HLTClassification code 10047750Term: Vulval neoplasms malignantSystem Organ Class: 100000004864
EUCTR2016-001191-30-DKDepartment of Obstetrics & Gynecology, Copenhagen University Hospital, Rigshospitalet70
招募中
不适用
The efficacy and safety of TachoSil as haemostatic treatment in robot assisted radical prostatectomyProstatic cancer
JPRN-UMIN000015473Division of Urology, Department of Surgery, Tottori University Faculty of Medicine1,000
进行中(未招募)
不适用
The Safety and Feasibility of TachoSil® application on connections of the esophagus.Anastomotic leakageMedDRA version: 14.1Level: LLTClassification code 10065961Term: Esophageal anastomotic leakSystem Organ Class: 10022117 - Injury, poisoning and procedural complicationsMedDRA version: 14.1Level: LLTClassification code 10065890Term: Oesophageal anastomotic leakSystem Organ Class: 10022117 - Injury, poisoning and procedural complications
EUCTR2011-005749-10-NLniversity Medical Center Utrecht